Skip to main content
TipRanks
Go Ultimate75% OFF

Bone Therapeutics (0R55) Financial Statements

2 Followers

Bone Therapeutics Financial Overview

Bone Therapeutics's market cap is currently €1.31M. The company's EPS TTM is €0.03; its P/E ratio is 0.06; and it has a dividend yield of 69.51%. Bone Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Jun 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 0.00€ 0.00€ 543.00K€ 296.00K€ 312.00K
Gross Profit€ 0.00€ -196.00K€ 543.00K€ 296.00K€ 987.00K
Operating Income€ -1.32M€ -8.27M€ -7.04M€ -2.32M€ -1.19M
EBITDA€ -1.32M€ -4.84M€ -6.80M€ -2.26M€ -864.00K
Net Income€ 20.93M€ -4.77M€ -28.78M€ -2.04M€ -984.00K
Balance Sheet
Cash & Short-Term Investments€ 69.00K€ 391.00K€ 117.00K€ 1.85M€ 759.00K
Total Assets€ 3.42M€ 4.74M€ 9.56M€ 29.32M€ 19.77M
Total Debt€ 3.81M€ 27.73M€ 28.52M€ 23.79M€ 3.52M
Net Debt€ 3.74M€ 27.34M€ 28.40M€ 18.99M€ 11.29M
Total Liabilities€ 5.37M€ 31.55M€ 32.26M€ 26.20M€ 26.54M
Stockholders' Equity€ -1.96M€ -25.07M€ -22.91M€ 3.53M€ -2.67M
Cash Flow
Free Cash Flow€ 0.00€ 0.00€ -3.47M€ -1.92M€ -12.99M
Operating Cash Flow€ -1.05M€ -2.23M€ -3.47M€ -1.91M€ -12.78M
Investing Cash Flow€ 29.00K€ 31.00K€ 6.00K€ 1.95M€ -204.00K
Financing Cash Flow€ 747.00K€ 2.48M€ 1.74M€ 1.04M€ 1.17M

Currency in EUR

Bone Therapeutics Earnings and Revenue History

-50M-25M025M-36000 %-24000 %-12000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Bone Therapeutics Liabilities to Assets

012M24M36M0 %250 %500 %750 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Bone Therapeutics Cash Flow

-20M-10M010M20M201720182019202020212022202320242025OperatingInvestingFinancing

Bone Therapeutics Forecast EPS vs Actual EPS

000000Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss